← Browse by Condition
Medical Condition

metastatic pancreatic adenocarcinoma

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3
NCT04115163 Phase 2
Recruiting

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Enrollment
67 pts
Location
United States
Sponsor
Anne Noonan
View Trial →
NCT01954992 Phase 3
Recruiting

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Enrollment
480 pts
Location
United States
Sponsor
Eleison Pharmaceuticals LLC.
View Trial →
NCT07226856 Phase 2
Recruiting

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Enrollment
43 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →